| Literature DB >> 15695821 |
Annett Schoenemeyer1, Betsy J Barnes, Margo E Mancl, Eicke Latz, Nadege Goutagny, Paula M Pitha, Katherine A Fitzgerald, Douglas T Golenbock.
Abstract
Interferon regulatory factors (IRFs) are critical components of virus-induced immune activation and type I interferon regulation. IRF3 and IRF7 are activated in response to a variety of viruses or after engagement of Toll-like receptor (TLR) 3 and TLR4 by double-stranded RNA and lipopolysaccharide, respectively. The activation of IRF5, is much more restricted. Here we show that in contrast to IRF3 and IRF7, IRF5 is not a target of the TLR3 signaling pathway but is activated by TLR7 or TLR8 signaling. We also demonstrate that MyD88, interleukin 1 receptor-associated kinase 1, and tumor necrosis factor receptor-associated factor 6 are required for the activation of IRF5 and IRF7 in the TLR7 signaling pathway. Moreover, ectopic expression of IRF5 enabled type I interferon production in response to TLR7 signaling, whereas knockdown of IRF5 by small interfering RNA reduced type I interferon induction in response to the TLR7 ligand, R-848. IRF5 and IRF7, therefore, emerge from these studies as critical mediators of TLR7 signaling.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15695821 DOI: 10.1074/jbc.M412584200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157